A month after the firm lost four life sciences and technology partners to Goodwin Procter, Taylor Wessing has started to reassemble its group with a new hire from Fieldfisher. Fieldfisher’s former life sciences and healthcare head Alison Dennis is to join Taylor Wessing after over a decade at Fieldfisher. As the head of the group, […]
Sidley Austin has been granted permission to appeal a June decision in one of The Lawyer’s Top 20 cases for 2019. Acting for Servier Laboratories in a drug patents dispute, Sidley Austin was originally denied the opportunity to take the case to the Supreme Court. However, On July 25, the Supreme Court said it would […]
Peters & Peters will continue with its preparation for the Servier dispute after the Court of Appeal dismissed the pharmaceutical company’s appeal against a judge’s decision that was handed down last year. The case, which is featured in The Lawyer’s Top 20 cases 2019, is due to be heard in October, but this was Servier’s […]
Kirkland & Ellis and Wachtell Lipton Rosen & Katz were the two lead US advisers on the $63bn transatlantic deal between pharmaceutical giants AbbVie and Allergan. AbbVie, an American biopharmaceutical company, has acquired Allergan, a Dublin-based botox-maker, in a cash and stock deal. The combined company is expected to increase leadership across healthcare fields such […]
Babylon’s general counsel Henry Bennett is dealing with multifaceted legal challenges at the digital health start-up.
Permission has been granted on s78 appeal for a 60 bed care home (Use Class C2) in Hartley Wintney, within Hart District Council: APP/N1730/W/18/3203638 James Corbet Burcher represented Forest Care in their appeal, instructed by Turley. The Appeal Decision examines the need for specialist elderly care accommodation, both at District and more local level, including […]
Which pharmaceuticals company has been the heaviest user of lawyers this year? Owner of the rights to EpiPen, Generics (UK) Ltd, trading as Mylan, has replaced Eli Lilly and Company as the most active pharmaceuticals company in court in 2018, according to Litigation Tracker’s data. During 2018, Generics (UK) instructed law firms in four cases, […]
NHS Commercial Solutions has rolled out a new legal panel, with firms including Addleshaw Goddard, Clyde & Co and DAC Beachcroft winning places. The three firms have been reappointed to the procurement organisation’s framework, as well as Mills & Reeve and Trowers & Hamlins. A total of 19 firms have made it on to the new roster; new additions are Browne Jacobson, Sintons, […]
The SHS V fund managed by Tübingen-based SHS Gesellschaft für Beteiligungsmanagement has acquired a joint stake in Swiss evitria AG together with AFINUM. The life science company supplies large pharmaceutical and biotech companies with customized antibodies for research purposes. SHS Gesellschaft für Beteiligungsmanagement is based in Tübingen, Germany and invests in medical technology and life […]
An Ogier team led by partners Simon Dinning and Nick Williams has advised Japan’s Takeda Pharmaceutical on its £46 billion (over £63 billion including Shire’s debt) acquisition of Shire, creating one of the world’s largest pharmaceutical firms. The deal is the largest ever foreign takeover by a Japanese company. The Ogier team advised on the […]
On Jan. 7, 2019, Fertin Pharma A/S announced that it had acquired Tab Labs Inc. Fertin Pharma, headquartered in Vejle, Denmark, is the leading independent B2B developer and manufacturer of medicated chewing gum, primarily nicotine chewing gum used for withdrawal management in the process of tobacco cessation. Tab Labs is a full-service, private label contract […]
Goodwin Procter has further expanded its European life sciences and technology practice, taking on a new partner from Taylor Wessing in London. Andrew Davis, who began his career at Allen & Overy, joins after a seven-year stint at Taylor Wessing, where he was made a partner in 2014. Davis has worked with clients such as […]